Overview

Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Study in healthy subjects to measure amount of drug in blood after dosing with different saxagliptin / metformin products.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Metformin
Saxagliptin